Anti-PAIP1 monoclonal antibody

Pre-made anti-PAIP1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PAIP1/PAIP1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2639-Ab-1/ GM-Tg-hg-IP2639-Ab-2Anti-Human PAIP1 monoclonal antibodyHuman
GM-Tg-rg-IP2639-Ab-1/ GM-Tg-rg-IP2639-Ab-2Anti-Rat PAIP1 monoclonal antibodyRat
GM-Tg-mg-IP2639-Ab-1/ GM-Tg-mg-IP2639-Ab-2Anti-Mouse PAIP1 monoclonal antibodyMouse
GM-Tg-cynog-IP2639-Ab-1/ GM-Tg-cynog-IP2639-Ab-2Anti-Cynomolgus/ Rhesus macaque PAIP1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2639-Ab-1/ GM-Tg-felg-IP2639-Ab-2Anti-Feline PAIP1 monoclonal antibodyFeline
GM-Tg-cang-IP2639-Ab-1/ GM-Tg-cang-IP2639-Ab-2Anti-Canine PAIP1 monoclonal antibodyCanine
GM-Tg-bovg-IP2639-Ab-1/ GM-Tg-bovg-IP2639-Ab-2Anti-Bovine PAIP1 monoclonal antibodyBovine
GM-Tg-equg-IP2639-Ab-1/ GM-Tg-equg-IP2639-Ab-2Anti-Equine PAIP1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2639-Ab-1/ GM-Tg-hg-IP2639-Ab-2; GM-Tg-rg-IP2639-Ab-1/ GM-Tg-rg-IP2639-Ab-2;
GM-Tg-mg-IP2639-Ab-1/ GM-Tg-mg-IP2639-Ab-2; GM-Tg-cynog-IP2639-Ab-1/ GM-Tg-cynog-IP2639-Ab-2;
GM-Tg-felg-IP2639-Ab-1/ GM-Tg-felg-IP2639-Ab-2; GM-Tg-cang-IP2639-Ab-1/ GM-Tg-cang-IP2639-Ab-2;
GM-Tg-bovg-IP2639-Ab-1/ GM-Tg-bovg-IP2639-Ab-2; GM-Tg-equg-IP2639-Ab-1/ GM-Tg-equg-IP2639-Ab-2
Products NameAnti-PAIP1 monoclonal antibody
Formatmab
Target NamePAIP1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PAIP1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2639-Ag-1Recombinant multi-species PAIP1 protein
    ORF Viral VectorpGMLPm002125mouse Paip1 Lentivirus plasmid
    ORF Viral VectorvGMLPm002125mouse Paip1 Lentivirus particle


    Target information

    Target IDGM-IP2639
    Target NamePAIP1
    Gene ID10605,218693,365684,700869,479343,101092995,510246,100064807
    Gene Symbol and SynonymsPAIP-1,PAIP1
    Uniprot AccessionQ9H074
    Uniprot Entry NamePAIP1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000172239
    Target ClassificationN/A

    The target: PAIP1, gene name: PAIP1, also named as . The protein encoded by this gene interacts with poly(A)-binding protein and with the cap-binding complex eIF4A. It is involved in translational initiation and protein biosynthesis. Overexpression of this gene in COS7 cells stimulates translation. Alternative splicing occurs at this locus and three transcript variants encoding three distinct isoforms have been identified. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.